nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—CYP2C9—Gefitinib—lung cancer	0.053	0.158	CbGbCtD
Secobarbital—CYP2C9—Teniposide—lung cancer	0.0514	0.154	CbGbCtD
Secobarbital—CYP2C8—Erlotinib—lung cancer	0.0449	0.134	CbGbCtD
Secobarbital—CYP2C8—Paclitaxel—lung cancer	0.0411	0.123	CbGbCtD
Secobarbital—CYP1A2—Erlotinib—lung cancer	0.0348	0.104	CbGbCtD
Secobarbital—CYP2C8—Etoposide—lung cancer	0.0325	0.0971	CbGbCtD
Secobarbital—CYP2C9—Paclitaxel—lung cancer	0.0287	0.0857	CbGbCtD
Secobarbital—CYP1A2—Etoposide—lung cancer	0.0251	0.0752	CbGbCtD
Secobarbital—CYP2C9—Cisplatin—lung cancer	0.0231	0.0689	CbGbCtD
Secobarbital—Hypoxia—Gefitinib—lung cancer	0.00897	0.0326	CcSEcCtD
Secobarbital—Respiratory failure—Crizotinib—lung cancer	0.00639	0.0232	CcSEcCtD
Secobarbital—Respiratory failure—Pemetrexed—lung cancer	0.00584	0.0212	CcSEcCtD
Secobarbital—Respiratory failure—Gefitinib—lung cancer	0.00581	0.0211	CcSEcCtD
Secobarbital—Anaemia megaloblastic—Methotrexate—lung cancer	0.00514	0.0187	CcSEcCtD
Secobarbital—Hypoxia—Vinorelbine—lung cancer	0.00464	0.0168	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Gefitinib—lung cancer	0.00439	0.0159	CcSEcCtD
Secobarbital—Hypoxia—Gemcitabine—lung cancer	0.00373	0.0135	CcSEcCtD
Secobarbital—Respiratory failure—Topotecan—lung cancer	0.00351	0.0127	CcSEcCtD
Secobarbital—Hepatocellular injury—Erlotinib—lung cancer	0.00341	0.0124	CcSEcCtD
Secobarbital—Bradycardia—Crizotinib—lung cancer	0.00321	0.0117	CcSEcCtD
Secobarbital—Respiratory failure—Vinorelbine—lung cancer	0.003	0.0109	CcSEcCtD
Secobarbital—Injection site reaction—Vinorelbine—lung cancer	0.00293	0.0106	CcSEcCtD
Secobarbital—Liver injury—Cisplatin—lung cancer	0.00262	0.00952	CcSEcCtD
Secobarbital—Syncope—Crizotinib—lung cancer	0.00246	0.00894	CcSEcCtD
Secobarbital—Loss of consciousness—Crizotinib—lung cancer	0.00241	0.00876	CcSEcCtD
Secobarbital—Respiratory failure—Gemcitabine—lung cancer	0.00241	0.00875	CcSEcCtD
Secobarbital—Apnoea—Etoposide—lung cancer	0.00238	0.00866	CcSEcCtD
Secobarbital—Injection site reaction—Gemcitabine—lung cancer	0.00235	0.00855	CcSEcCtD
Secobarbital—Angioedema—Gefitinib—lung cancer	0.00228	0.00827	CcSEcCtD
Secobarbital—Syncope—Pemetrexed—lung cancer	0.00225	0.00817	CcSEcCtD
Secobarbital—Hepatocellular injury—Cisplatin—lung cancer	0.00221	0.00801	CcSEcCtD
Secobarbital—Loss of consciousness—Pemetrexed—lung cancer	0.0022	0.008	CcSEcCtD
Secobarbital—Shock—Crizotinib—lung cancer	0.0022	0.008	CcSEcCtD
Secobarbital—Thinking abnormal—Paclitaxel—lung cancer	0.00217	0.00786	CcSEcCtD
Secobarbital—Respiratory failure—Paclitaxel—lung cancer	0.00202	0.00733	CcSEcCtD
Secobarbital—Shock—Pemetrexed—lung cancer	0.00201	0.00731	CcSEcCtD
Secobarbital—Shock—Gefitinib—lung cancer	0.002	0.00727	CcSEcCtD
Secobarbital—Injection site reaction—Paclitaxel—lung cancer	0.00197	0.00715	CcSEcCtD
Secobarbital—Constipation—Crizotinib—lung cancer	0.00192	0.00696	CcSEcCtD
Secobarbital—Hypoxia—Methotrexate—lung cancer	0.00191	0.00692	CcSEcCtD
Secobarbital—Hypotension—Gefitinib—lung cancer	0.0019	0.0069	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Irinotecan—lung cancer	0.00187	0.00679	CcSEcCtD
Secobarbital—Agitation—Teniposide—lung cancer	0.00187	0.00678	CcSEcCtD
Secobarbital—Body temperature increased—Crizotinib—lung cancer	0.00177	0.00643	CcSEcCtD
Secobarbital—Constipation—Pemetrexed—lung cancer	0.00175	0.00636	CcSEcCtD
Secobarbital—Constipation—Gefitinib—lung cancer	0.00174	0.00632	CcSEcCtD
Secobarbital—Mental disability—Paclitaxel—lung cancer	0.00172	0.00625	CcSEcCtD
Secobarbital—Respiratory failure—Docetaxel—lung cancer	0.00171	0.00621	CcSEcCtD
Secobarbital—Phenobarbital—ABCC3—lung cancer	0.00171	0.212	CrCbGaD
Secobarbital—Hepatocellular injury—Docetaxel—lung cancer	0.00168	0.0061	CcSEcCtD
Secobarbital—Confusional state—Teniposide—lung cancer	0.00167	0.00607	CcSEcCtD
Secobarbital—Injection site reaction—Docetaxel—lung cancer	0.00167	0.00606	CcSEcCtD
Secobarbital—Body temperature increased—Pemetrexed—lung cancer	0.00162	0.00588	CcSEcCtD
Secobarbital—Body temperature increased—Gefitinib—lung cancer	0.00161	0.00584	CcSEcCtD
Secobarbital—Hypotension—Teniposide—lung cancer	0.00155	0.00563	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Paclitaxel—lung cancer	0.00152	0.00554	CcSEcCtD
Secobarbital—Hypersensitivity—Pemetrexed—lung cancer	0.00151	0.00548	CcSEcCtD
Secobarbital—Hypersensitivity—Gefitinib—lung cancer	0.0015	0.00544	CcSEcCtD
Secobarbital—Dizziness—Crizotinib—lung cancer	0.00148	0.00538	CcSEcCtD
Secobarbital—Amobarbital—CYP2A6—lung cancer	0.00147	0.183	CrCbGaD
Secobarbital—Apnoea—Methotrexate—lung cancer	0.00143	0.00519	CcSEcCtD
Secobarbital—Vomiting—Crizotinib—lung cancer	0.00142	0.00517	CcSEcCtD
Secobarbital—Rash—Crizotinib—lung cancer	0.00141	0.00513	CcSEcCtD
Secobarbital—Dermatitis—Crizotinib—lung cancer	0.00141	0.00512	CcSEcCtD
Secobarbital—Angioedema—Topotecan—lung cancer	0.00138	0.005	CcSEcCtD
Secobarbital—Feeling abnormal—Teniposide—lung cancer	0.00137	0.00496	CcSEcCtD
Secobarbital—Dizziness—Pemetrexed—lung cancer	0.00135	0.00492	CcSEcCtD
Secobarbital—Ataxia—Paclitaxel—lung cancer	0.00135	0.00491	CcSEcCtD
Secobarbital—Syncope—Erlotinib—lung cancer	0.00134	0.00485	CcSEcCtD
Secobarbital—Nausea—Crizotinib—lung cancer	0.00133	0.00483	CcSEcCtD
Secobarbital—Body temperature increased—Teniposide—lung cancer	0.00131	0.00476	CcSEcCtD
Secobarbital—Loss of consciousness—Erlotinib—lung cancer	0.00131	0.00475	CcSEcCtD
Secobarbital—Vomiting—Pemetrexed—lung cancer	0.0013	0.00473	CcSEcCtD
Secobarbital—Vomiting—Gefitinib—lung cancer	0.00129	0.0047	CcSEcCtD
Secobarbital—Rash—Pemetrexed—lung cancer	0.00129	0.00469	CcSEcCtD
Secobarbital—Dermatitis—Pemetrexed—lung cancer	0.00129	0.00468	CcSEcCtD
Secobarbital—Rash—Gefitinib—lung cancer	0.00128	0.00466	CcSEcCtD
Secobarbital—Dermatitis—Gefitinib—lung cancer	0.00128	0.00465	CcSEcCtD
Secobarbital—Anxiety—Erlotinib—lung cancer	0.00126	0.00459	CcSEcCtD
Secobarbital—Liver injury—Doxorubicin—lung cancer	0.00125	0.00452	CcSEcCtD
Secobarbital—Bradycardia—Irinotecan—lung cancer	0.00124	0.00451	CcSEcCtD
Secobarbital—Pentobarbital—CYP2A6—lung cancer	0.00124	0.154	CrCbGaD
Secobarbital—Respiratory failure—Methotrexate—lung cancer	0.00123	0.00448	CcSEcCtD
Secobarbital—Hypersensitivity—Teniposide—lung cancer	0.00122	0.00444	CcSEcCtD
Secobarbital—Nausea—Pemetrexed—lung cancer	0.00122	0.00442	CcSEcCtD
Secobarbital—Nausea—Gefitinib—lung cancer	0.00121	0.00439	CcSEcCtD
Secobarbital—Shock—Erlotinib—lung cancer	0.0012	0.00434	CcSEcCtD
Secobarbital—Angioedema—Vinorelbine—lung cancer	0.00118	0.00427	CcSEcCtD
Secobarbital—Depressed level of consciousness—Methotrexate—lung cancer	0.00117	0.00425	CcSEcCtD
Secobarbital—Ataxia—Docetaxel—lung cancer	0.00115	0.00416	CcSEcCtD
Secobarbital—Thinking abnormal—Doxorubicin—lung cancer	0.00115	0.00416	CcSEcCtD
Secobarbital—Bradycardia—Cisplatin—lung cancer	0.00113	0.0041	CcSEcCtD
Secobarbital—Constipation—Vinblastine—lung cancer	0.00108	0.00393	CcSEcCtD
Secobarbital—Thiopental—CYP2E1—lung cancer	0.00106	0.131	CrCbGaD
Secobarbital—Vomiting—Teniposide—lung cancer	0.00105	0.00383	CcSEcCtD
Secobarbital—Constipation—Topotecan—lung cancer	0.00105	0.00382	CcSEcCtD
Secobarbital—Hepatocellular injury—Doxorubicin—lung cancer	0.00105	0.00381	CcSEcCtD
Secobarbital—Rash—Teniposide—lung cancer	0.00105	0.0038	CcSEcCtD
Secobarbital—Dermatitis—Teniposide—lung cancer	0.00104	0.00379	CcSEcCtD
Secobarbital—Feeling abnormal—Vinblastine—lung cancer	0.00104	0.00379	CcSEcCtD
Secobarbital—Injection site reaction—Doxorubicin—lung cancer	0.00104	0.00378	CcSEcCtD
Secobarbital—Constipation—Erlotinib—lung cancer	0.00104	0.00378	CcSEcCtD
Secobarbital—Headache—Teniposide—lung cancer	0.00104	0.00377	CcSEcCtD
Secobarbital—Bradycardia—Paclitaxel—lung cancer	0.00101	0.00368	CcSEcCtD
Secobarbital—Feeling abnormal—Topotecan—lung cancer	0.00101	0.00368	CcSEcCtD
Secobarbital—Nausea—Teniposide—lung cancer	0.000985	0.00358	CcSEcCtD
Secobarbital—Hypotension—Vinorelbine—lung cancer	0.000982	0.00357	CcSEcCtD
Secobarbital—Body temperature increased—Topotecan—lung cancer	0.000972	0.00353	CcSEcCtD
Secobarbital—Body temperature increased—Erlotinib—lung cancer	0.000961	0.00349	CcSEcCtD
Secobarbital—Syncope—Irinotecan—lung cancer	0.000953	0.00346	CcSEcCtD
Secobarbital—Loss of consciousness—Irinotecan—lung cancer	0.000934	0.00339	CcSEcCtD
Secobarbital—Hypersensitivity—Vinblastine—lung cancer	0.000932	0.00338	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Methotrexate—lung cancer	0.000932	0.00338	CcSEcCtD
Secobarbital—Phenobarbital—CYP2A6—lung cancer	0.000926	0.115	CrCbGaD
Secobarbital—Mental disability—Doxorubicin—lung cancer	0.00091	0.0033	CcSEcCtD
Secobarbital—Hypersensitivity—Topotecan—lung cancer	0.000905	0.00329	CcSEcCtD
Secobarbital—Constipation—Vinorelbine—lung cancer	0.000899	0.00326	CcSEcCtD
Secobarbital—Confusional state—Irinotecan—lung cancer	0.000874	0.00317	CcSEcCtD
Secobarbital—Feeling abnormal—Vinorelbine—lung cancer	0.000866	0.00315	CcSEcCtD
Secobarbital—Shock—Irinotecan—lung cancer	0.000853	0.0031	CcSEcCtD
Secobarbital—Tension—Paclitaxel—lung cancer	0.00085	0.00309	CcSEcCtD
Secobarbital—Nervousness—Paclitaxel—lung cancer	0.000842	0.00306	CcSEcCtD
Secobarbital—Dizziness—Vinblastine—lung cancer	0.000837	0.00304	CcSEcCtD
Secobarbital—Body temperature increased—Vinorelbine—lung cancer	0.000831	0.00302	CcSEcCtD
Secobarbital—Ataxia—Methotrexate—lung cancer	0.000826	0.003	CcSEcCtD
Secobarbital—Anxiety—Cisplatin—lung cancer	0.000818	0.00297	CcSEcCtD
Secobarbital—Dizziness—Topotecan—lung cancer	0.000813	0.00295	CcSEcCtD
Secobarbital—Hypotension—Irinotecan—lung cancer	0.00081	0.00294	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000807	0.00293	CcSEcCtD
Secobarbital—Vomiting—Vinblastine—lung cancer	0.000804	0.00292	CcSEcCtD
Secobarbital—Dizziness—Erlotinib—lung cancer	0.000804	0.00292	CcSEcCtD
Secobarbital—Agitation—Paclitaxel—lung cancer	0.000796	0.00289	CcSEcCtD
Secobarbital—Headache—Vinblastine—lung cancer	0.000793	0.00288	CcSEcCtD
Secobarbital—Angioedema—Paclitaxel—lung cancer	0.000792	0.00287	CcSEcCtD
Secobarbital—Hypotension—Gemcitabine—lung cancer	0.000789	0.00287	CcSEcCtD
Secobarbital—Vomiting—Topotecan—lung cancer	0.000781	0.00284	CcSEcCtD
Secobarbital—Syncope—Paclitaxel—lung cancer	0.000777	0.00282	CcSEcCtD
Secobarbital—Loss of consciousness—Etoposide—lung cancer	0.000777	0.00282	CcSEcCtD
Secobarbital—Rash—Topotecan—lung cancer	0.000775	0.00281	CcSEcCtD
Secobarbital—Hypersensitivity—Vinorelbine—lung cancer	0.000775	0.00281	CcSEcCtD
Secobarbital—Dermatitis—Topotecan—lung cancer	0.000774	0.00281	CcSEcCtD
Secobarbital—Vomiting—Erlotinib—lung cancer	0.000773	0.00281	CcSEcCtD
Secobarbital—Somnolence—Irinotecan—lung cancer	0.000771	0.0028	CcSEcCtD
Secobarbital—Headache—Topotecan—lung cancer	0.00077	0.0028	CcSEcCtD
Secobarbital—Rash—Erlotinib—lung cancer	0.000767	0.00278	CcSEcCtD
Secobarbital—Dermatitis—Erlotinib—lung cancer	0.000766	0.00278	CcSEcCtD
Secobarbital—Headache—Erlotinib—lung cancer	0.000762	0.00277	CcSEcCtD
Secobarbital—Loss of consciousness—Paclitaxel—lung cancer	0.000762	0.00277	CcSEcCtD
Secobarbital—Nausea—Vinblastine—lung cancer	0.000751	0.00273	CcSEcCtD
Secobarbital—Somnolence—Gemcitabine—lung cancer	0.000751	0.00273	CcSEcCtD
Secobarbital—Constipation—Irinotecan—lung cancer	0.000741	0.00269	CcSEcCtD
Secobarbital—Hypotension—Cisplatin—lung cancer	0.000736	0.00267	CcSEcCtD
Secobarbital—Anxiety—Paclitaxel—lung cancer	0.000735	0.00267	CcSEcCtD
Secobarbital—Nausea—Topotecan—lung cancer	0.00073	0.00265	CcSEcCtD
Secobarbital—Confusional state—Etoposide—lung cancer	0.000727	0.00264	CcSEcCtD
Secobarbital—Constipation—Gemcitabine—lung cancer	0.000722	0.00262	CcSEcCtD
Secobarbital—Nausea—Erlotinib—lung cancer	0.000722	0.00262	CcSEcCtD
Secobarbital—Ataxia—Doxorubicin—lung cancer	0.000716	0.0026	CcSEcCtD
Secobarbital—Feeling abnormal—Irinotecan—lung cancer	0.000715	0.00259	CcSEcCtD
Secobarbital—Confusional state—Paclitaxel—lung cancer	0.000713	0.00259	CcSEcCtD
Secobarbital—Feeling abnormal—Gemcitabine—lung cancer	0.000696	0.00253	CcSEcCtD
Secobarbital—Shock—Paclitaxel—lung cancer	0.000696	0.00253	CcSEcCtD
Secobarbital—Dizziness—Vinorelbine—lung cancer	0.000695	0.00252	CcSEcCtD
Secobarbital—Body temperature increased—Irinotecan—lung cancer	0.000685	0.00249	CcSEcCtD
Secobarbital—Hypotension—Etoposide—lung cancer	0.000674	0.00245	CcSEcCtD
Secobarbital—Vomiting—Vinorelbine—lung cancer	0.000668	0.00243	CcSEcCtD
Secobarbital—Body temperature increased—Gemcitabine—lung cancer	0.000668	0.00242	CcSEcCtD
Secobarbital—Rash—Vinorelbine—lung cancer	0.000663	0.00241	CcSEcCtD
Secobarbital—Dermatitis—Vinorelbine—lung cancer	0.000662	0.0024	CcSEcCtD
Secobarbital—Hypotension—Paclitaxel—lung cancer	0.000661	0.0024	CcSEcCtD
Secobarbital—Headache—Vinorelbine—lung cancer	0.000659	0.00239	CcSEcCtD
Secobarbital—Syncope—Docetaxel—lung cancer	0.000659	0.00239	CcSEcCtD
Secobarbital—Phenobarbital—CYP2E1—lung cancer	0.000658	0.0817	CrCbGaD
Secobarbital—Phenobarbital—CYP1A1—lung cancer	0.000649	0.0806	CrCbGaD
Secobarbital—Feeling abnormal—Cisplatin—lung cancer	0.000649	0.00236	CcSEcCtD
Secobarbital—Loss of consciousness—Docetaxel—lung cancer	0.000645	0.00234	CcSEcCtD
Secobarbital—Somnolence—Etoposide—lung cancer	0.000641	0.00233	CcSEcCtD
Secobarbital—Hypersensitivity—Irinotecan—lung cancer	0.000639	0.00232	CcSEcCtD
Secobarbital—Somnolence—Paclitaxel—lung cancer	0.000629	0.00228	CcSEcCtD
Secobarbital—Nausea—Vinorelbine—lung cancer	0.000624	0.00227	CcSEcCtD
Secobarbital—Body temperature increased—Cisplatin—lung cancer	0.000622	0.00226	CcSEcCtD
Secobarbital—Constipation—Etoposide—lung cancer	0.000617	0.00224	CcSEcCtD
Secobarbital—Constipation—Paclitaxel—lung cancer	0.000605	0.0022	CcSEcCtD
Secobarbital—Confusional state—Docetaxel—lung cancer	0.000604	0.00219	CcSEcCtD
Secobarbital—Feeling abnormal—Etoposide—lung cancer	0.000594	0.00216	CcSEcCtD
Secobarbital—Shock—Docetaxel—lung cancer	0.00059	0.00214	CcSEcCtD
Secobarbital—Feeling abnormal—Paclitaxel—lung cancer	0.000583	0.00212	CcSEcCtD
Secobarbital—Hypersensitivity—Cisplatin—lung cancer	0.00058	0.00211	CcSEcCtD
Secobarbital—Dizziness—Irinotecan—lung cancer	0.000573	0.00208	CcSEcCtD
Secobarbital—Body temperature increased—Etoposide—lung cancer	0.00057	0.00207	CcSEcCtD
Secobarbital—Hypotension—Docetaxel—lung cancer	0.00056	0.00203	CcSEcCtD
Secobarbital—Body temperature increased—Paclitaxel—lung cancer	0.000559	0.00203	CcSEcCtD
Secobarbital—Vomiting—Irinotecan—lung cancer	0.000551	0.002	CcSEcCtD
Secobarbital—Rash—Irinotecan—lung cancer	0.000547	0.00199	CcSEcCtD
Secobarbital—Dermatitis—Irinotecan—lung cancer	0.000546	0.00198	CcSEcCtD
Secobarbital—Headache—Irinotecan—lung cancer	0.000543	0.00197	CcSEcCtD
Secobarbital—Vomiting—Gemcitabine—lung cancer	0.000537	0.00195	CcSEcCtD
Secobarbital—Bradycardia—Doxorubicin—lung cancer	0.000536	0.00195	CcSEcCtD
Secobarbital—Somnolence—Docetaxel—lung cancer	0.000533	0.00193	CcSEcCtD
Secobarbital—Rash—Gemcitabine—lung cancer	0.000533	0.00193	CcSEcCtD
Secobarbital—Dermatitis—Gemcitabine—lung cancer	0.000532	0.00193	CcSEcCtD
Secobarbital—Hypersensitivity—Etoposide—lung cancer	0.000531	0.00193	CcSEcCtD
Secobarbital—Headache—Gemcitabine—lung cancer	0.000529	0.00192	CcSEcCtD
Secobarbital—Hypersensitivity—Paclitaxel—lung cancer	0.000521	0.00189	CcSEcCtD
Secobarbital—Nausea—Irinotecan—lung cancer	0.000515	0.00187	CcSEcCtD
Secobarbital—Constipation—Docetaxel—lung cancer	0.000513	0.00186	CcSEcCtD
Secobarbital—Nausea—Gemcitabine—lung cancer	0.000502	0.00182	CcSEcCtD
Secobarbital—Vomiting—Cisplatin—lung cancer	0.000501	0.00182	CcSEcCtD
Secobarbital—Rash—Cisplatin—lung cancer	0.000496	0.0018	CcSEcCtD
Secobarbital—Dermatitis—Cisplatin—lung cancer	0.000496	0.0018	CcSEcCtD
Secobarbital—Feeling abnormal—Docetaxel—lung cancer	0.000494	0.00179	CcSEcCtD
Secobarbital—Dizziness—Etoposide—lung cancer	0.000477	0.00173	CcSEcCtD
Secobarbital—Body temperature increased—Docetaxel—lung cancer	0.000474	0.00172	CcSEcCtD
Secobarbital—Dizziness—Paclitaxel—lung cancer	0.000468	0.0017	CcSEcCtD
Secobarbital—Nausea—Cisplatin—lung cancer	0.000468	0.0017	CcSEcCtD
Secobarbital—Vomiting—Etoposide—lung cancer	0.000459	0.00167	CcSEcCtD
Secobarbital—Rash—Etoposide—lung cancer	0.000455	0.00165	CcSEcCtD
Secobarbital—Dermatitis—Etoposide—lung cancer	0.000454	0.00165	CcSEcCtD
Secobarbital—Headache—Etoposide—lung cancer	0.000452	0.00164	CcSEcCtD
Secobarbital—Tension—Doxorubicin—lung cancer	0.00045	0.00163	CcSEcCtD
Secobarbital—Vomiting—Paclitaxel—lung cancer	0.00045	0.00163	CcSEcCtD
Secobarbital—Rash—Paclitaxel—lung cancer	0.000446	0.00162	CcSEcCtD
Secobarbital—Dermatitis—Paclitaxel—lung cancer	0.000445	0.00162	CcSEcCtD
Secobarbital—Nervousness—Doxorubicin—lung cancer	0.000445	0.00162	CcSEcCtD
Secobarbital—Headache—Paclitaxel—lung cancer	0.000443	0.00161	CcSEcCtD
Secobarbital—Hypersensitivity—Docetaxel—lung cancer	0.000442	0.0016	CcSEcCtD
Secobarbital—Confusional state—Methotrexate—lung cancer	0.000436	0.00158	CcSEcCtD
Secobarbital—Nausea—Etoposide—lung cancer	0.000428	0.00156	CcSEcCtD
Secobarbital—Agitation—Doxorubicin—lung cancer	0.000421	0.00153	CcSEcCtD
Secobarbital—Nausea—Paclitaxel—lung cancer	0.00042	0.00153	CcSEcCtD
Secobarbital—Syncope—Doxorubicin—lung cancer	0.000411	0.00149	CcSEcCtD
Secobarbital—Hypotension—Methotrexate—lung cancer	0.000404	0.00147	CcSEcCtD
Secobarbital—Loss of consciousness—Doxorubicin—lung cancer	0.000403	0.00146	CcSEcCtD
Secobarbital—Dizziness—Docetaxel—lung cancer	0.000396	0.00144	CcSEcCtD
Secobarbital—Anxiety—Doxorubicin—lung cancer	0.000389	0.00141	CcSEcCtD
Secobarbital—Somnolence—Methotrexate—lung cancer	0.000384	0.00139	CcSEcCtD
Secobarbital—Vomiting—Docetaxel—lung cancer	0.000381	0.00138	CcSEcCtD
Secobarbital—Rash—Docetaxel—lung cancer	0.000378	0.00137	CcSEcCtD
Secobarbital—Dermatitis—Docetaxel—lung cancer	0.000378	0.00137	CcSEcCtD
Secobarbital—Confusional state—Doxorubicin—lung cancer	0.000377	0.00137	CcSEcCtD
Secobarbital—Headache—Docetaxel—lung cancer	0.000375	0.00136	CcSEcCtD
Secobarbital—Shock—Doxorubicin—lung cancer	0.000368	0.00134	CcSEcCtD
Secobarbital—Nausea—Docetaxel—lung cancer	0.000356	0.00129	CcSEcCtD
Secobarbital—Feeling abnormal—Methotrexate—lung cancer	0.000356	0.00129	CcSEcCtD
Secobarbital—Hypotension—Doxorubicin—lung cancer	0.00035	0.00127	CcSEcCtD
Secobarbital—Phenobarbital—ABCB1—lung cancer	0.000345	0.0428	CrCbGaD
Secobarbital—Body temperature increased—Methotrexate—lung cancer	0.000342	0.00124	CcSEcCtD
Secobarbital—Somnolence—Doxorubicin—lung cancer	0.000333	0.00121	CcSEcCtD
Secobarbital—Constipation—Doxorubicin—lung cancer	0.00032	0.00116	CcSEcCtD
Secobarbital—Hypersensitivity—Methotrexate—lung cancer	0.000318	0.00116	CcSEcCtD
Secobarbital—Feeling abnormal—Doxorubicin—lung cancer	0.000308	0.00112	CcSEcCtD
Secobarbital—Body temperature increased—Doxorubicin—lung cancer	0.000296	0.00107	CcSEcCtD
Secobarbital—Dizziness—Methotrexate—lung cancer	0.000286	0.00104	CcSEcCtD
Secobarbital—Hypersensitivity—Doxorubicin—lung cancer	0.000276	0.001	CcSEcCtD
Secobarbital—Vomiting—Methotrexate—lung cancer	0.000275	0.000997	CcSEcCtD
Secobarbital—Rash—Methotrexate—lung cancer	0.000272	0.000989	CcSEcCtD
Secobarbital—Dermatitis—Methotrexate—lung cancer	0.000272	0.000988	CcSEcCtD
Secobarbital—Headache—Methotrexate—lung cancer	0.000271	0.000983	CcSEcCtD
Secobarbital—Nausea—Methotrexate—lung cancer	0.000257	0.000932	CcSEcCtD
Secobarbital—Dizziness—Doxorubicin—lung cancer	0.000247	0.000898	CcSEcCtD
Secobarbital—Vomiting—Doxorubicin—lung cancer	0.000238	0.000864	CcSEcCtD
Secobarbital—Rash—Doxorubicin—lung cancer	0.000236	0.000856	CcSEcCtD
Secobarbital—Dermatitis—Doxorubicin—lung cancer	0.000236	0.000856	CcSEcCtD
Secobarbital—Headache—Doxorubicin—lung cancer	0.000234	0.000851	CcSEcCtD
Secobarbital—Nausea—Doxorubicin—lung cancer	0.000222	0.000807	CcSEcCtD
Secobarbital—GABRA5—Transmembrane transport of small molecules—APOA1—lung cancer	5.77e-05	0.000151	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.72e-05	0.00015	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—HRAS—lung cancer	5.68e-05	0.000149	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—APOA1—lung cancer	5.66e-05	0.000148	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.64e-05	0.000148	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—HRAS—lung cancer	5.62e-05	0.000147	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—APOA1—lung cancer	5.56e-05	0.000146	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—CREBBP—lung cancer	5.56e-05	0.000146	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—lung cancer	5.52e-05	0.000145	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—CREBBP—lung cancer	5.49e-05	0.000144	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—APOA1—lung cancer	5.43e-05	0.000142	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—lung cancer	5.42e-05	0.000142	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—COL4A3BP—lung cancer	5.33e-05	0.00014	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—AZIN2—lung cancer	5.33e-05	0.00014	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—lung cancer	5.33e-05	0.00014	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HSD17B10—lung cancer	5.32e-05	0.000139	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ATP5H—lung cancer	5.31e-05	0.000139	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	5.31e-05	0.000139	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—POMC—lung cancer	5.29e-05	0.000139	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—ALB—lung cancer	5.21e-05	0.000136	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	5.2e-05	0.000136	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—ALB—lung cancer	5.14e-05	0.000135	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—CREBBP—lung cancer	5.02e-05	0.000132	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.97e-05	0.00013	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CKB—lung cancer	4.94e-05	0.000129	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—CREBBP—lung cancer	4.88e-05	0.000128	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.88e-05	0.000128	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—HRAS—lung cancer	4.82e-05	0.000126	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.82e-05	0.000126	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—CREBBP—lung cancer	4.79e-05	0.000125	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—HRAS—lung cancer	4.76e-05	0.000125	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	4.74e-05	0.000124	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PLBD1—lung cancer	4.73e-05	0.000124	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—CREBBP—lung cancer	4.71e-05	0.000123	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—lung cancer	4.71e-05	0.000123	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—ALB—lung cancer	4.7e-05	0.000123	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.65e-05	0.000122	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—lung cancer	4.65e-05	0.000122	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CNDP2—lung cancer	4.65e-05	0.000122	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTM2—lung cancer	4.65e-05	0.000122	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	4.59e-05	0.00012	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—ALB—lung cancer	4.57e-05	0.00012	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	4.54e-05	0.000119	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ATP5H—lung cancer	4.54e-05	0.000119	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—POMC—lung cancer	4.52e-05	0.000118	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MTMR3—lung cancer	4.52e-05	0.000118	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—ALB—lung cancer	4.49e-05	0.000117	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—ALB—lung cancer	4.41e-05	0.000115	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PGAM1—lung cancer	4.41e-05	0.000115	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—HRAS—lung cancer	4.36e-05	0.000114	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HSD17B10—lung cancer	4.33e-05	0.000113	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	4.3e-05	0.000113	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—RAF1—lung cancer	4.25e-05	0.000111	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—HRAS—lung cancer	4.23e-05	0.000111	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2A7—lung cancer	4.2e-05	0.00011	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.17e-05	0.000109	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—HRAS—lung cancer	4.15e-05	0.000109	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—lung cancer	4.13e-05	0.000108	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SDC4—lung cancer	4.11e-05	0.000108	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—HRAS—lung cancer	4.08e-05	0.000107	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—lung cancer	4.06e-05	0.000106	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PLBD1—lung cancer	4.04e-05	0.000106	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CKB—lung cancer	4.02e-05	0.000105	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.02e-05	0.000105	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—lung cancer	3.99e-05	0.000104	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—HRAS—lung cancer	3.98e-05	0.000104	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.98e-05	0.000104	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	3.89e-05	0.000102	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CNDP2—lung cancer	3.78e-05	9.9e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTM2—lung cancer	3.78e-05	9.9e-05	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	3.76e-05	9.84e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—RRM1—lung cancer	3.75e-05	9.81e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA3—lung cancer	3.75e-05	9.81e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HSD17B10—lung cancer	3.7e-05	9.68e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MTMR3—lung cancer	3.68e-05	9.63e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PGAM1—lung cancer	3.59e-05	9.39e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—B4GALT5—lung cancer	3.52e-05	9.22e-05	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—HRAS—lung cancer	3.48e-05	9.11e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CKB—lung cancer	3.44e-05	9e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA4—lung cancer	3.43e-05	8.97e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2A7—lung cancer	3.42e-05	8.95e-05	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	3.4e-05	8.9e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.35e-05	8.77e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SDC4—lung cancer	3.35e-05	8.76e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA2—lung cancer	3.34e-05	8.74e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTM2—lung cancer	3.23e-05	8.46e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CNDP2—lung cancer	3.23e-05	8.46e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA1—lung cancer	3.22e-05	8.43e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCC3—lung cancer	3.18e-05	8.34e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MTMR3—lung cancer	3.14e-05	8.23e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—AKR1C1—lung cancer	3.08e-05	8.07e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PGAM1—lung cancer	3.06e-05	8.02e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—RRM1—lung cancer	3.05e-05	7.98e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA3—lung cancer	3.05e-05	7.98e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—UGT1A1—lung cancer	2.99e-05	7.84e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2A7—lung cancer	2.92e-05	7.65e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GNG11—lung cancer	2.89e-05	7.56e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.87e-05	7.52e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—B4GALT5—lung cancer	2.87e-05	7.5e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SDC4—lung cancer	2.86e-05	7.49e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA4—lung cancer	2.79e-05	7.3e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALDOA—lung cancer	2.75e-05	7.2e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.73e-05	7.13e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA2—lung cancer	2.72e-05	7.11e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NCOA3—lung cancer	2.67e-05	6.99e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.62e-05	6.87e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA1—lung cancer	2.62e-05	6.86e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA3—lung cancer	2.61e-05	6.82e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—RRM1—lung cancer	2.61e-05	6.82e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ADCY1—lung cancer	2.6e-05	6.8e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCG2—lung cancer	2.6e-05	6.8e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCC3—lung cancer	2.59e-05	6.79e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ENO2—lung cancer	2.55e-05	6.67e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HPGDS—lung cancer	2.55e-05	6.67e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PPP2R1B—lung cancer	2.53e-05	6.62e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—AKR1C1—lung cancer	2.51e-05	6.57e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.5e-05	6.54e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTT1—lung cancer	2.47e-05	6.46e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—B4GALT5—lung cancer	2.45e-05	6.41e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2A6—lung cancer	2.44e-05	6.39e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GCLC—lung cancer	2.44e-05	6.39e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—UGT1A1—lung cancer	2.44e-05	6.38e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.43e-05	6.37e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA4—lung cancer	2.38e-05	6.24e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GNG11—lung cancer	2.35e-05	6.15e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.34e-05	6.12e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.33e-05	6.1e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA2—lung cancer	2.32e-05	6.08e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ENO1—lung cancer	2.31e-05	6.06e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.31e-05	6.04e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.28e-05	5.96e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA1—lung cancer	2.24e-05	5.86e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALDOA—lung cancer	2.24e-05	5.86e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCC3—lung cancer	2.22e-05	5.8e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NCOA3—lung cancer	2.17e-05	5.69e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—AKR1C1—lung cancer	2.15e-05	5.62e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.13e-05	5.59e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCG2—lung cancer	2.11e-05	5.53e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ADCY1—lung cancer	2.11e-05	5.53e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—UGT1A1—lung cancer	2.08e-05	5.45e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2E1—lung cancer	2.08e-05	5.43e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ENO2—lung cancer	2.07e-05	5.42e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HPGDS—lung cancer	2.07e-05	5.42e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PPP2R1B—lung cancer	2.06e-05	5.39e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NQO1—lung cancer	2.05e-05	5.37e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.03e-05	5.32e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTT1—lung cancer	2.01e-05	5.26e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.01e-05	5.26e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GNG11—lung cancer	2.01e-05	5.26e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2e-05	5.23e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.99e-05	5.21e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GCLC—lung cancer	1.99e-05	5.2e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2A6—lung cancer	1.99e-05	5.2e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.98e-05	5.18e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALDOA—lung cancer	1.91e-05	5.01e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ENO1—lung cancer	1.88e-05	4.93e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.88e-05	4.91e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NCOA3—lung cancer	1.86e-05	4.86e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.85e-05	4.85e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—STK11—lung cancer	1.85e-05	4.84e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.82e-05	4.77e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ADCY1—lung cancer	1.81e-05	4.73e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCG2—lung cancer	1.81e-05	4.73e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ENO2—lung cancer	1.77e-05	4.64e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HPGDS—lung cancer	1.77e-05	4.64e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.76e-05	4.61e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.74e-05	4.55e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.74e-05	4.55e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTT1—lung cancer	1.72e-05	4.5e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTP1—lung cancer	1.71e-05	4.48e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GCLC—lung cancer	1.7e-05	4.44e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2A6—lung cancer	1.7e-05	4.44e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.69e-05	4.43e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2E1—lung cancer	1.69e-05	4.42e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NQO1—lung cancer	1.67e-05	4.37e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CAT—lung cancer	1.67e-05	4.36e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.66e-05	4.34e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.64e-05	4.28e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.62e-05	4.24e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCB1—lung cancer	1.62e-05	4.24e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ENO1—lung cancer	1.61e-05	4.21e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.6e-05	4.2e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TYMS—lung cancer	1.59e-05	4.17e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.58e-05	4.14e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTM1—lung cancer	1.57e-05	4.12e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—STK11—lung cancer	1.51e-05	3.94e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP1A1—lung cancer	1.49e-05	3.9e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ERCC2—lung cancer	1.48e-05	3.87e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2E1—lung cancer	1.44e-05	3.78e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NQO1—lung cancer	1.43e-05	3.74e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.41e-05	3.7e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.4e-05	3.66e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTP1—lung cancer	1.39e-05	3.65e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.38e-05	3.63e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CAT—lung cancer	1.36e-05	3.55e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.35e-05	3.53e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCB1—lung cancer	1.32e-05	3.45e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TYMS—lung cancer	1.3e-05	3.39e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—STK11—lung cancer	1.29e-05	3.37e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTM1—lung cancer	1.28e-05	3.35e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—APOA1—lung cancer	1.28e-05	3.35e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.23e-05	3.21e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP1A1—lung cancer	1.21e-05	3.18e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.21e-05	3.16e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ERCC2—lung cancer	1.2e-05	3.15e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTP1—lung cancer	1.19e-05	3.12e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CG—lung cancer	1.17e-05	3.06e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CAT—lung cancer	1.16e-05	3.03e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.15e-05	3.02e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCB1—lung cancer	1.13e-05	2.95e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—POMC—lung cancer	1.11e-05	2.91e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TYMS—lung cancer	1.11e-05	2.9e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTM1—lung cancer	1.09e-05	2.86e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CREBBP—lung cancer	1.08e-05	2.83e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—APOA1—lung cancer	1.04e-05	2.73e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP1A1—lung cancer	1.04e-05	2.71e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ERCC2—lung cancer	1.03e-05	2.69e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CD—lung cancer	1.03e-05	2.69e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ALB—lung cancer	1.01e-05	2.65e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.97e-06	2.61e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CG—lung cancer	9.51e-06	2.49e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—POMC—lung cancer	9.05e-06	2.37e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CB—lung cancer	8.95e-06	2.34e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—APOA1—lung cancer	8.9e-06	2.33e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTGS2—lung cancer	8.87e-06	2.32e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CREBBP—lung cancer	8.81e-06	2.31e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.52e-06	2.23e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CD—lung cancer	8.36e-06	2.19e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ALB—lung cancer	8.25e-06	2.16e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CG—lung cancer	8.12e-06	2.13e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTEN—lung cancer	7.73e-06	2.02e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—POMC—lung cancer	7.73e-06	2.02e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CREBBP—lung cancer	7.53e-06	1.97e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—EP300—lung cancer	7.38e-06	1.93e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CB—lung cancer	7.28e-06	1.91e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTGS2—lung cancer	7.22e-06	1.89e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CD—lung cancer	7.14e-06	1.87e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ALB—lung cancer	7.05e-06	1.85e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTEN—lung cancer	6.29e-06	1.65e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CB—lung cancer	6.22e-06	1.63e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTGS2—lung cancer	6.17e-06	1.61e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—EP300—lung cancer	6e-06	1.57e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PIK3CA—lung cancer	5.46e-06	1.43e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTEN—lung cancer	5.38e-06	1.41e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—EP300—lung cancer	5.13e-06	1.34e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—AKT1—lung cancer	4.46e-06	1.17e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PIK3CA—lung cancer	4.44e-06	1.16e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PIK3CA—lung cancer	3.79e-06	9.93e-06	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—AKT1—lung cancer	3.63e-06	9.5e-06	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—AKT1—lung cancer	3.1e-06	8.11e-06	CbGpPWpGaD
